Francisco J. Esteva/LinkedIn
Dec 13, 2024, 16:50
Francisco J. Esteva: The clinical validation results of Ataraxis Breast at SABCS24
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared on LinkedIn:
“Very informative poster presentation by Jan Witowski at the 2024 San Antonio Breast Cancer Symposium.
The clinical validation results of Ataraxis Breast–the first AI-native prognostic/predictive test for breast cancer patients are impressive.
Looking forward to continuing our collaboration with Ataraxis AI on the validation and implementation of AI prognostic and predictive models at Northwell Cancer Institute.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 12:06
Mar 29, 2025, 12:00
Mar 29, 2025, 11:58
Mar 29, 2025, 11:36
Mar 29, 2025, 11:26
Mar 29, 2025, 11:03
Mar 29, 2025, 10:55
Mar 29, 2025, 10:45